These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31774391)

  • 21. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells.
    Chareonsirisuthigul T; Kalayanarooj S; Ubol S
    J Gen Virol; 2007 Feb; 88(Pt 2):365-375. PubMed ID: 17251552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse models of dengue virus infection for vaccine testing.
    Sarathy VV; Milligan GN; Bourne N; Barrett AD
    Vaccine; 2015 Dec; 33(50):7051-60. PubMed ID: 26478201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dengue Virus and Zika Virus Serological Cross-reactivity and Their Impact on Pathogenesis in Mice.
    Watanabe S; Tan NWW; Chan KWK; Vasudevan SG
    J Infect Dis; 2019 Jan; 219(2):223-233. PubMed ID: 30085051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in complement alternative pathway components, factor B and factor H during dengue virus infection in the AG129 mouse.
    Cabezas-Falcon S; Norbury AJ; Hulme-Jones J; Klebe S; Adamson P; Rudd PA; Mahalingam S; Ong LC; Alonso S; Gordon DL; Carr JM
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33410734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human T Cell Response to Dengue Virus Infection.
    Tian Y; Grifoni A; Sette A; Weiskopf D
    Front Immunol; 2019; 10():2125. PubMed ID: 31552052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice.
    Milligan GN; Sarathy VV; Infante E; Li L; Campbell GA; Beatty PR; Harris E; Barrett AD; Bourne N
    PLoS One; 2015; 10(5):e0125476. PubMed ID: 25938762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice.
    Zellweger RM; Eddy WE; Tang WW; Miller R; Shresta S
    J Immunol; 2014 Oct; 193(8):4117-24. PubMed ID: 25217165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines.
    Borges MB; Marchevsky RS; Carvalho Pereira R; da Silva Mendes Y; Almeida Mendes LG; Diniz-Mendes L; Cruz MA; Tahmaoui O; Baudart S; Freire M; Homma A; Schneider-Ohrum K; Vaughn DW; Vanloubbeeck Y; Lorin C; Malice MP; Caride E; Warter L
    PLoS Pathog; 2019 Apr; 15(4):e1007721. PubMed ID: 31009499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Innate Lymphoid Cells Activation and Transcriptomic Changes in Response to Human Dengue Infection.
    Poonpanichakul T; Chan-In W; Opasawatchai A; Loison F; Matangkasombut O; Charoensawan V; Matangkasombut P;
    Front Immunol; 2021; 12():599805. PubMed ID: 34079535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dengue Virus M Protein Promotes NLRP3 Inflammasome Activation To Induce Vascular Leakage in Mice.
    Pan P; Zhang Q; Liu W; Wang W; Lao Z; Zhang W; Shen M; Wan P; Xiao F; Liu F; Zhang W; Tan Q; Liu X; Wu K; Liu Y; Li G; Wu J
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional Profiling Confirms the Therapeutic Effects of Mast Cell Stabilization in a Dengue Disease Model.
    Morrison J; Rathore APS; Mantri CK; Aman SAB; Nishida A; St John AL
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28659489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo roles of sphingosine kinase 2 during dengue virus infection.
    Al-Shujairi WH; Clarke JN; Davies LT; Pitman MR; Calvert JK; Aloia AL; Pitson SM; Carr JM
    J Gen Virol; 2019 Apr; 100(4):629-641. PubMed ID: 30869582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability.
    Puerta-Guardo H; Raya-Sandino A; González-Mariscal L; Rosales VH; Ayala-Dávila J; Chávez-Mungía B; Martínez-Fong D; Medina F; Ludert JE; del Angel RM
    J Virol; 2013 Jul; 87(13):7486-501. PubMed ID: 23616663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower activation-induced T-cell apoptosis is related to the pathological immune response in secondary infection with hetero-serotype dengue virus.
    Yang W; Yan H; Ma Y; Yu T; Guo H; Kuang Y; Ren R; Li J
    Immunobiology; 2016 Mar; 221(3):432-9. PubMed ID: 26655144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.
    Hertz T; Beatty PR; MacMillen Z; Killingbeck SS; Wang C; Harris E
    J Immunol; 2017 May; 198(10):4025-4035. PubMed ID: 28381638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infection.
    Valiant WG; Huang YS; Vanlandingham DL; Higgs S; Lewis MG; Mattapallil JJ
    Emerg Microbes Infect; 2018 Jul; 7(1):130. PubMed ID: 30006514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression profile of human peripheral blood mononuclear cell miRNA is altered by antibody-dependent enhancement of infection with dengue virus serotype 3.
    Jiang L; Sun Q
    Virol J; 2018 Mar; 15(1):50. PubMed ID: 29566761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dengue Virus Infects Primary Human Hair Follicle Dermal Papilla Cells.
    Wei KC; Huang MS; Chang TH
    Front Cell Infect Microbiol; 2018; 8():268. PubMed ID: 30186771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dengue Virus Infection of Primary Endothelial Cells Induces Innate Immune Responses, Changes in Endothelial Cells Function and Is Restricted by Interferon-Stimulated Responses.
    Calvert JK; Helbig KJ; Dimasi D; Cockshell M; Beard MR; Pitson SM; Bonder CS; Carr JM
    J Interferon Cytokine Res; 2015 Aug; 35(8):654-65. PubMed ID: 25902155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal Antibody-Mediated Disease Enhancement in Type I Interferon-Deficient Mice Leads to Lethal Disease Associated with Liver Damage.
    Martínez Gómez JM; Ong LC; Lam JH; Binte Aman SA; Libau EA; Lee PX; St John AL; Alonso S
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004536. PubMed ID: 27007501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.